Clinical Trial

To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

Study acronym: PETRiS
Recruiting
View on ClinicalTrials.gov →
Summary
This registry study aims to evaluate the effectiveness and clinical impact of specimen PET-CT imaging by analyzing the correlation between specimen PET-CT images, intraoperative interpretations, and histopathological findings. Additionally, it assesses how these imaging insights influence clinical decision-making and long-term patient outcomes. Through this comprehensive analysis in a real-world setting, the study seeks to generate valuable insights that can enhance specimen evaluation processes and ultimately improve patient care.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-05; most recent amendment 2026-07-23.
Status change: Not Yet Recruiting → Recruiting 2025-11-27
Trial Details
NCT Number NCT06970275
Lead Sponsor XEOS Medical
Conditions Prostate Cancers, Breast Cancer, Head and Neck Cancer, Cancer
Enrollment 850 participants
Start Date 2025-11-19
Primary Completion 2031-01-15 (estimated)
Study Completion 2031-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-24